This comprehensive strategic report provides a detailed analysis of the Global Ephrin Type B Receptor 4 (EPHB4) Market, assessing its clinical status, competitive landscape, and growth potential for the 2026–2036 forecast period.
Global Ephrin Type B Receptor 4 (EPHB4) Market: Strategic Analysis & Forecast (2026–2036)
1. Market Overview
Ephrin Type B Receptor 4 (EPHB4) is a member of the ephrin receptor subfamily of the protein-tyrosine kinase family. Its primary significance lies in its over-expression in various cancers and its critical role in tumor angiogenesis and vascular remodeling. As of 2025, the market is characterized by a robust pipeline of targeted therapies and diagnostic agents aimed at treating metastatic solid tumors and rare cancers.
-
Market Status (2025): Estimated at USD 512 Million (primarily Clinical R&D and Early Adoption).
-
Projected Valuation (2036): Expected to reach USD 1.28 Billion.
-
CAGR (2026–2036): Projected at 8.7%.
2. Key Players
Beyond the initial clinical biotech firms, the market is increasingly influenced by large-scale pharmaceutical giants through acquisitions and licensing agreements:
-
Sanofi (Kadmon Holdings): Following the acquisition of Kadmon, Sanofi leads the development of Tesevatinib.
-
Eisai Co., Ltd.: Investigating EPHB4 inhibitors in combination with their existing oncology portfolio (Lenvatinib).
-
VasGene Therapeutics, Inc.: A pioneer in EPHB4-HSA (Human Serum Albumin) fusion proteins.
-
AstraZeneca PLC: Exploring ephrin pathways within their broader DNA Damage Response (DDR) and antibody-drug conjugate (ADC) research.
-
Bristol Myers Squibb (BMS): Researching the role of EPHB4 in immunotherapy resistance.
-
Merck & Co., Inc.: Investigating EPHB4 as a biomarker for anti-PD-1 therapy responsiveness.
-
Hengrui Medicine: Emerging Chinese leader in tyrosine kinase inhibitor (TKI) development targeting the ephrin family.
3. Comprehensive Segment Analysis
By Product/Molecule Type
-
Fusion Proteins (e.g., sEphB4-HSA): Designed to act as a "decoy" to block ephrin-B2 interaction; currently showing high efficacy in clinical trials.
-
Tyrosine Kinase Inhibitors (TKIs): Small molecules like Tesevatinib Tosylate that inhibit intracellular signaling.
-
Monoclonal Antibodies (mAbs): Targeted agents designed to trigger immune responses against EPHB4-expressing cells.
-
Antibody-Drug Conjugates (ADCs): Emerging segment using EPHB4 as a vehicle to deliver cytotoxic payloads directly to tumors.
By Application/Indication
-
Solid Tumors: The largest segment, including breast, prostate, and lung cancers.
-
Bile Duct Cancer (Cholangiocarcinoma): High unmet need area where EPHB4 targeted therapies are receiving orphan drug designations.
-
Colorectal Cancer: Focus on overcoming resistance to standard anti-VEGF therapies.
-
Head and Neck Squamous Cell Carcinoma (HNSCC): Emerging segment with promising phase II trial data.
-
Kaposi Sarcoma: Researching the role of EPHB4 in viral-induced oncogenesis.
4. Regional Analysis
-
North America: Dominates the market (approx. 42% share) due to high investment in precision medicine and a high concentration of clinical trials at institutes like MD Anderson and MSKCC.
-
Europe: Second-largest market; growth driven by the EMA’s supportive framework for orphan drugs in oncology.
-
Asia-Pacific: The fastest-growing region (CAGR of 10.2%). China and India are expanding their clinical trial infrastructure and domestic drug manufacturing capabilities.
-
LAMEA: Emerging interest in Brazil and Saudi Arabia as specialized oncology centers adopt next-gen sequencing (NGS) to identify EPHB4 targets.
5. Porter’s Five Forces Analysis
-
Bargaining Power of Suppliers (Moderate): Suppliers of specialized biologics and clinical-grade reagents are limited but professional.
-
Bargaining Power of Buyers (High): Governments and insurance providers (payers) exert extreme pressure on oncology drug pricing.
-
Threat of New Entrants (Low): Formidable barriers include the necessity for deep biological expertise, long clinical trial timelines (10+ years), and stringent FDA/EMA regulations.
-
Threat of Substitutes (Moderate): Rival pathways (VEGF, EGFR, HER2) offer alternative targets, though EPHB4 is often used when these fail.
-
Competitive Rivalry (High): Intense competition among biotech firms to be the first to move from Phase II to Phase III trials.
6. SWOT Analysis
-
Strengths: High specificity for tumor vasculature; potential to overcome resistance to traditional anti-angiogenics.
-
Weaknesses: Complexity of the EPHB4/Ephrin-B2 bidirectional signaling; high cost of biologics manufacturing.
-
Opportunities: Expansion into combination therapies with Checkpoint Inhibitors (PD-1/CTLA-4); potential as a diagnostic biomarker.
-
Threats: High failure rates in Phase III clinical trials; emergence of generic TKIs in unrelated pathways lowering overall treatment costs.
7. Trend Analysis
-
Combination Therapies: The industry is moving away from monotherapy, focusing on combining EPHB4 inhibitors with immunotherapy to "heat up" cold tumors.
-
Precision Biomarkers: Development of companion diagnostics to identify patients with high EPHB4 expression before treatment.
-
Vascular Normalization: Rather than just destroying vessels, new trends focus on using EPHB4 to normalize tumor vasculature to improve the delivery of chemotherapy.
8. Drivers & Challenges
-
Driver: The global increase in cancer prevalence and the shift toward "personalized" oncology.
-
Driver: Significant funding from venture capital and government grants for "First-in-Class" therapeutic targets.
-
Challenge: The bidirectional nature of EPHB4—in some contexts, it can act as a tumor suppressor, requiring highly precise modulation.
-
Challenge: Regulatory hurdles regarding the long-term safety of modulating vascular remodeling pathways.
9. Value Chain Analysis
-
Target Discovery: Academic and genomic research identifying EPHB4 overexpression.
-
Drug Synthesis: Manufacturing of fusion proteins and small molecules.
-
Clinical Trials: Rigorous Phase I-III testing for safety and efficacy.
-
Regulatory Approval: Filing for FDA/EMA marketing authorization.
-
Distribution & Market Access: High-specialty pharmacy distribution and oncology center administration.
10. Quick Recommendations for Stakeholders
-
For Manufacturers: Focus on Combination Data. Payers are more likely to reimburse new EPHB4 agents if they demonstrate a "synergistic effect" with existing low-cost treatments.
-
For Investors: Target companies with Orphan Drug Designations in Bile Duct or Head and Neck cancers, as these provide faster paths to market and extended exclusivity.
-
For Healthcare Providers: Implement Biomarker Screening protocols to ensure EPHB4 targeted therapies are only administered to patients most likely to respond, optimizing cost-effectiveness.
-
For Clinical Researchers: Explore the pediatric oncology applications for EPHB4, as vascular-targeted therapies show promise in certain rare childhood sarcomas.
Table of Contents
Global Ephrin Type B Receptor 4 Sales Market Report 2018
1 Ephrin Type B Receptor 4 Market Overview
1.1 Product Overview and Scope of Ephrin Type B Receptor 4
1.2 Classification of Ephrin Type B Receptor 4 by Product Category
1.2.1 Global Ephrin Type B Receptor 4 Market Size (Sales) Comparison by Type
1.2.2 Global Ephrin Type B Receptor 4 Market Size (Sales) Market Share by Type (Product Category) in
1.2.3 VDAU-11
1.2.4 Vas-01
1.2.5 Tesevatinib Tosylate
1.2.6 Others
1.3 Global Ephrin Type B Receptor 4 Market by Application/End Users
1.3.1 Global Ephrin Type B Receptor 4 Sales (Volume) and Market Share Comparison by Application
1.3.1 Solid Tumor
1.3.2 Bile Duct Cancer
1.3.3 Colorectal Cancer
1.3.4 Melanoma
1.3.5 Others
1.4 Global Ephrin Type B Receptor 4 Market by Region
1.4.1 Global Ephrin Type B Receptor 4 Market Size (Value) Comparison by Region
1.4.2 United States Ephrin Type B Receptor 4 Status and Prospect
1.4.3 Europe Ephrin Type B Receptor 4 Status and Prospect
1.4.4 China Ephrin Type B Receptor 4 Status and Prospect
1.4.5 Japan Ephrin Type B Receptor 4 Status and Prospect
1.4.6 Southeast Asia Ephrin Type B Receptor 4 Status and Prospect
1.4.7 India Ephrin Type B Receptor 4 Status and Prospect
1.5 Global Market Size (Value and Volume) of Ephrin Type B Receptor 4
1.5.1 Global Ephrin Type B Receptor 4 Sales and Growth Rate
1.5.2 Global Ephrin Type B Receptor 4 Revenue and Growth Rate
2 Global Ephrin Type B Receptor 4 Competition by Players/Suppliers, Type and Application
2.1 Global Ephrin Type B Receptor 4 Market Competition by Players/Suppliers
2.1.1 Global Ephrin Type B Receptor 4 Sales and Market Share of Key Players/Suppliers ()
2.1.2 Global Ephrin Type B Receptor 4 Revenue and Share by Players/Suppliers ()
2.2 Global Ephrin Type B Receptor 4 (Volume and Value) by Type
2.2.1 Global Ephrin Type B Receptor 4 Sales and Market Share by Type ()
2.2.2 Global Ephrin Type B Receptor 4 Revenue and Market Share by Type ()
2.3 Global Ephrin Type B Receptor 4 (Volume and Value) by Region
2.3.1 Global Ephrin Type B Receptor 4 Sales and Market Share by Region ()
2.3.2 Global Ephrin Type B Receptor 4 Revenue and Market Share by Region ()
2.4 Global Ephrin Type B Receptor 4 (Volume) by Application
3 United States Ephrin Type B Receptor 4 (Volume, Value and Sales Price)
3.1 United States Ephrin Type B Receptor 4 Sales and Value ()
3.1.1 United States Ephrin Type B Receptor 4 Sales and Growth Rate ()
3.1.2 United States Ephrin Type B Receptor 4 Revenue and Growth Rate ()
3.1.3 United States Ephrin Type B Receptor 4 Sales Price Trend ()
3.2 United States Ephrin Type B Receptor 4 Sales Volume and Market Share by Players ()
3.3 United States Ephrin Type B Receptor 4 Sales Volume and Market Share by Type ()
3.4 United States Ephrin Type B Receptor 4 Sales Volume and Market Share by Application ()
4 Europe Ephrin Type B Receptor 4 (Volume, Value and Sales Price)
4.1 Europe Ephrin Type B Receptor 4 Sales and Value ()
4.1.1 Europe Ephrin Type B Receptor 4 Sales and Growth Rate ()
4.1.2 Europe Ephrin Type B Receptor 4 Revenue and Growth Rate ()
4.1.3 Europe Ephrin Type B Receptor 4 Sales Price Trend ()
4.2 Europe Ephrin Type B Receptor 4 Sales Volume and Market Share by Players ()
4.3 Europe Ephrin Type B Receptor 4 Sales Volume and Market Share by Type ()
4.4 Europe Ephrin Type B Receptor 4 Sales Volume and Market Share by Application ()
5 China Ephrin Type B Receptor 4 (Volume, Value and Sales Price)
5.1 China Ephrin Type B Receptor 4 Sales and Value ()
5.1.1 China Ephrin Type B Receptor 4 Sales and Growth Rate ()
5.1.2 China Ephrin Type B Receptor 4 Revenue and Growth Rate ()
5.1.3 China Ephrin Type B Receptor 4 Sales Price Trend ()
5.2 China Ephrin Type B Receptor 4 Sales Volume and Market Share by Players ()
5.3 China Ephrin Type B Receptor 4 Sales Volume and Market Share by Type ()
5.4 China Ephrin Type B Receptor 4 Sales Volume and Market Share by Application ()
6 Japan Ephrin Type B Receptor 4 (Volume, Value and Sales Price)
6.1 Japan Ephrin Type B Receptor 4 Sales and Value ()
6.1.1 Japan Ephrin Type B Receptor 4 Sales and Growth Rate ()
6.1.2 Japan Ephrin Type B Receptor 4 Revenue and Growth Rate ()
6.1.3 Japan Ephrin Type B Receptor 4 Sales Price Trend ()
6.2 Japan Ephrin Type B Receptor 4 Sales Volume and Market Share by Players ()
6.3 Japan Ephrin Type B Receptor 4 Sales Volume and Market Share by Type ()
6.4 Japan Ephrin Type B Receptor 4 Sales Volume and Market Share by Application ()
7 Southeast Asia Ephrin Type B Receptor 4 (Volume, Value and Sales Price)
7.1 Southeast Asia Ephrin Type B Receptor 4 Sales and Value ()
7.1.1 Southeast Asia Ephrin Type B Receptor 4 Sales and Growth Rate ()
7.1.2 Southeast Asia Ephrin Type B Receptor 4 Revenue and Growth Rate ()
7.1.3 Southeast Asia Ephrin Type B Receptor 4 Sales Price Trend ()
7.2 Southeast Asia Ephrin Type B Receptor 4 Sales Volume and Market Share by Players ()
7.3 Southeast Asia Ephrin Type B Receptor 4 Sales Volume and Market Share by Type ()
7.4 Southeast Asia Ephrin Type B Receptor 4 Sales Volume and Market Share by Application ()
8 India Ephrin Type B Receptor 4 (Volume, Value and Sales Price)
8.1 India Ephrin Type B Receptor 4 Sales and Value ()
8.1.1 India Ephrin Type B Receptor 4 Sales and Growth Rate ()
8.1.2 India Ephrin Type B Receptor 4 Revenue and Growth Rate ()
8.1.3 India Ephrin Type B Receptor 4 Sales Price Trend ()
8.2 India Ephrin Type B Receptor 4 Sales Volume and Market Share by Players ()
8.3 India Ephrin Type B Receptor 4 Sales Volume and Market Share by Type ()
8.4 India Ephrin Type B Receptor 4 Sales Volume and Market Share by Application ()
9 Global Ephrin Type B Receptor 4 Players/Suppliers Profiles and Sales Data
9.1 Eisai Co Ltd
9.1.1 Company Basic Information, Manufacturing Base and Competitors
9.1.2 Ephrin Type B Receptor 4 Product Category, Application and Specification
9.1.2.1 Product A
9.1.2.2 Product B
9.1.3 Eisai Co Ltd Ephrin Type B Receptor 4 Sales, Revenue, Price and Gross Margin ()
9.1.4 Main Business/Business Overview
9.2 Kadmon Corp LLC
9.2.1 Company Basic Information, Manufacturing Base and Competitors
9.2.2 Ephrin Type B Receptor 4 Product Category, Application and Specification
9.2.2.1 Product A
9.2.2.2 Product B
9.2.3 Kadmon Corp LLC Ephrin Type B Receptor 4 Sales, Revenue, Price and Gross Margin ()
9.2.4 Main Business/Business Overview
9.3 VasGene Therapeutics Inc
9.3.1 Company Basic Information, Manufacturing Base and Competitors
9.3.2 Ephrin Type B Receptor 4 Product Category, Application and Specification
9.3.2.1 Product A
9.3.2.2 Product B
9.3.3 VasGene Therapeutics Inc Ephrin Type B Receptor 4 Sales, Revenue, Price and Gross Margin ()
9.3.4 Main Business/Business Overview
...
10 Ephrin Type B Receptor 4 Maufacturing Cost Analysis
10.1 Ephrin Type B Receptor 4 Key Raw Materials Analysis
10.1.1 Key Raw Materials
10.1.2 Price Trend of Key Raw Materials
10.1.3 Key Suppliers of Raw Materials
10.1.4 Market Concentration Rate of Raw Materials
10.2 Proportion of Manufacturing Cost Structure
10.2.1 Raw Materials
10.2.2 Labor Cost
10.2.3 Manufacturing Process Analysis of Ephrin Type B Receptor 4
10.3 Manufacturing Process Analysis of Ephrin Type B Receptor 4
11 Industrial Chain, Sourcing Strategy and Downstream Buyers
11.1 Ephrin Type B Receptor 4 Industrial Chain Analysis
11.2 Upstream Raw Materials Sourcing
11.3 Raw Materials Sources of Ephrin Type B Receptor 4 Major Manufacturers in
11.4 Downstream Buyers
12 Marketing Strategy Analysis, Distributors/Traders
12.1 Marketing Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.1.3 Marketing Channel Development Trend
12.2 Market Positioning
12.2.1 Pricing Strategy
12.2.2 Brand Strategy
12.2.3 Target Client
12.3 Distributors/Traders List
13 Market Effect Factors Analysis
13.1 Technology Progress/Risk
13.1.1 Substitutes Threat
13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs/Customer Preference Change
13.3 Economic/Political Environmental Change
14 Global Ephrin Type B Receptor 4 Market Forecast (2018-2025)
14.1 Global Ephrin Type B Receptor 4 Sales Volume, Revenue and Price Forecast (2018-2025)
14.1.1 Global Ephrin Type B Receptor 4 Sales Volume and Growth Rate Forecast (2018-2025)
14.1.2 Global Ephrin Type B Receptor 4 Revenue and Growth Rate Forecast (2018-2025)
14.1.3 Global Ephrin Type B Receptor 4 Price and Trend Forecast (2018-2025)
14.2 Global Ephrin Type B Receptor 4 Sales Volume, Revenue and Growth Rate Forecast by Region (2018-2025)
14.2.1 Global Ephrin Type B Receptor 4 Sales Volume and Growth Rate Forecast by Regions (2018-2025)
14.2.2 Global Ephrin Type B Receptor 4 Revenue and Growth Rate Forecast by Regions (2018-2025)
14.2.3 United States Ephrin Type B Receptor 4 Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.2.4 Europe Ephrin Type B Receptor 4 Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.2.5 China Ephrin Type B Receptor 4 Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.2.6 Japan Ephrin Type B Receptor 4 Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.2.7 Southeast Asia Ephrin Type B Receptor 4 Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.2.8 India Ephrin Type B Receptor 4 Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.3 Global Ephrin Type B Receptor 4 Sales Volume, Revenue and Price Forecast by Type (2018-2025)
14.3.1 Global Ephrin Type B Receptor 4 Sales Forecast by Type (2018-2025)
14.3.2 Global Ephrin Type B Receptor 4 Revenue Forecast by Type (2018-2025)
14.3.3 Global Ephrin Type B Receptor 4 Price Forecast by Type (2018-2025)
14.4 Global Ephrin Type B Receptor 4 Sales Volume Forecast by Application (2018-2025)
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology/Research Approach
16.1.1 Research Programs/Design
16.1.2 Market Size Estimation
16.1.3 Market Breakdown and Data Triangulation
16.2 Data Source
16.2.1 Secondary Sources
16.2.2 Primary Sources
16.3 Disclaimer
List of Tables and Figures
Figure Product Picture of Ephrin Type B Receptor 4
Figure Global Ephrin Type B Receptor 4 Sales Volume Comparison (K Pcs) by Type
Figure Global Ephrin Type B Receptor 4 Sales Volume Market Share by Type (Product Category) in
Figure VDAU-11 Product Picture
Figure Vas-01 Product Picture
Figure Tesevatinib Tosylate Product Picture
Figure Others Product Picture
Figure Global Ephrin Type B Receptor 4 Sales Comparison (K Pcs) by Application
Figure Global Sales Market Share of Ephrin Type B Receptor 4 by Application in
Figure Solid Tumor Examples
Table Key Downstream Customer in Solid Tumor
Figure Bile Duct Cancer Examples
Table Key Downstream Customer in Bile Duct Cancer
Figure Colorectal Cancer Examples
Table Key Downstream Customer in Colorectal Cancer
Figure Melanoma Examples
Table Key Downstream Customer in Melanoma
Figure Others Examples
Table Key Downstream Customer in Others
Figure Global Ephrin Type B Receptor 4 Market Size (Million USD) by Regions
Figure United States Ephrin Type B Receptor 4 Revenue (Million USD) and Growth Rate
Figure Europe Ephrin Type B Receptor 4 Revenue (Million USD) and Growth Rate
Figure China Ephrin Type B Receptor 4 Revenue (Million USD) and Growth Rate
Figure Japan Ephrin Type B Receptor 4 Revenue (Million USD) and Growth Rate
Figure Southeast Asia Ephrin Type B Receptor 4 Revenue (Million USD) and Growth Rate
Figure India Ephrin Type B Receptor 4 Revenue (Million USD) and Growth Rate
Figure Global Ephrin Type B Receptor 4 Sales Volume (K Pcs) and Growth Rate
Figure Global Ephrin Type B Receptor 4 Revenue (Million USD) and Growth Rate
Figure Global Market Major Players Ephrin Type B Receptor 4 Sales Volume (K Pcs) ()
Table Global Ephrin Type B Receptor 4 Sales (K Pcs) of Key Players/Suppliers ()
Table Global Ephrin Type B Receptor 4 Sales Share by Players/Suppliers ()
Figure Ephrin Type B Receptor 4 Sales Share by Players/Suppliers
Figure Ephrin Type B Receptor 4 Sales Share by Players/Suppliers
Figure Global Ephrin Type B Receptor 4 Revenue (Million USD) by Players/Suppliers ()
Table Global Ephrin Type B Receptor 4 Revenue (Million USD) by Players/Suppliers ()
Table Global Ephrin Type B Receptor 4 Revenue Share by Players/Suppliers ()
Table Global Ephrin Type B Receptor 4 Revenue Share by Players
Table Global Ephrin Type B Receptor 4 Revenue Share by Players
Table Global Ephrin Type B Receptor 4 Sales (K Pcs) and Market Share by Type ()
Table Global Ephrin Type B Receptor 4 Sales Share (K Pcs) by Type ()
Figure Sales Market Share of Ephrin Type B Receptor 4 by Type ()
Figure Global Ephrin Type B Receptor 4 Sales Growth Rate by Type ()
Table Global Ephrin Type B Receptor 4 Revenue (Million USD) and Market Share by Type ()
Table Global Ephrin Type B Receptor 4 Revenue Share by Type ()
Figure Revenue Market Share of Ephrin Type B Receptor 4 by Type ()
Figure Global Ephrin Type B Receptor 4 Revenue Growth Rate by Type ()
Table Global Ephrin Type B Receptor 4 Sales Volume (K Pcs) and Market Share by Region ()
Table Global Ephrin Type B Receptor 4 Sales Share by Region ()
Figure Sales Market Share of Ephrin Type B Receptor 4 by Region ()
Figure Global Ephrin Type B Receptor 4 Sales Growth Rate by Region in
Table Global Ephrin Type B Receptor 4 Revenue (Million USD) and Market Share by Region ()
Table Global Ephrin Type B Receptor 4 Revenue Share (%) by Region ()
Figure Revenue Market Share of Ephrin Type B Receptor 4 by Region ()
Figure Global Ephrin Type B Receptor 4 Revenue Growth Rate by Region in
Table Global Ephrin Type B Receptor 4 Revenue (Million USD) and Market Share by Region ()
Table Global Ephrin Type B Receptor 4 Revenue Share (%) by Region ()
Figure Revenue Market Share of Ephrin Type B Receptor 4 by Region ()
Figure Global Ephrin Type B Receptor 4 Revenue Market Share by Region in
Table Global Ephrin Type B Receptor 4 Sales Volume (K Pcs) and Market Share by Application ()
Table Global Ephrin Type B Receptor 4 Sales Share (%) by Application ()
Figure Sales Market Share of Ephrin Type B Receptor 4 by Application ()
Figure Global Ephrin Type B Receptor 4 Sales Market Share by Application ()
Figure United States Ephrin Type B Receptor 4 Sales (K Pcs) and Growth Rate ()
Figure United States Ephrin Type B Receptor 4 Revenue (Million USD) and Growth Rate ()
Figure United States Ephrin Type B Receptor 4 Sales Price (USD/Pcs) Trend ()
Table United States Ephrin Type B Receptor 4 Sales Volume (K Pcs) by Players ()
Table United States Ephrin Type B Receptor 4 Sales Volume Market Share by Players ()
Figure United States Ephrin Type B Receptor 4 Sales Volume Market Share by Players in
Table United States Ephrin Type B Receptor 4 Sales Volume (K Pcs) by Type ()
Table United States Ephrin Type B Receptor 4 Sales Volume Market Share by Type ()
Figure United States Ephrin Type B Receptor 4 Sales Volume Market Share by Type in
Table United States Ephrin Type B Receptor 4 Sales Volume (K Pcs) by Application ()
Table United States Ephrin Type B Receptor 4 Sales Volume Market Share by Application ()
Figure United States Ephrin Type B Receptor 4 Sales Volume Market Share by Application in
Figure Europe Ephrin Type B Receptor 4 Sales (K Pcs) and Growth Rate ()
Figure Europe Ephrin Type B Receptor 4 Revenue (Million USD) and Growth Rate ()
Figure Europe Ephrin Type B Receptor 4 Sales Price (USD/Pcs) Trend ()
Table Europe Ephrin Type B Receptor 4 Sales Volume (K Pcs) by Players ()
Table Europe Ephrin Type B Receptor 4 Sales Volume Market Share by Players ()
Figure Europe Ephrin Type B Receptor 4 Sales Volume Market Share by Players in
Table Europe Ephrin Type B Receptor 4 Sales Volume (K Pcs) by Type ()
Table Europe Ephrin Type B Receptor 4 Sales Volume Market Share by Type ()
Figure Europe Ephrin Type B Receptor 4 Sales Volume Market Share by Type in
Table Europe Ephrin Type B Receptor 4 Sales Volume (K Pcs) by Application ()
Table Europe Ephrin Type B Receptor 4 Sales Volume Market Share by Application ()
Figure Europe Ephrin Type B Receptor 4 Sales Volume Market Share by Application in
Figure China Ephrin Type B Receptor 4 Sales (K Pcs) and Growth Rate ()
Figure China Ephrin Type B Receptor 4 Revenue (Million USD) and Growth Rate ()
Figure China Ephrin Type B Receptor 4 Sales Price (USD/Pcs) Trend ()
Table China Ephrin Type B Receptor 4 Sales Volume (K Pcs) by Players ()
Table China Ephrin Type B Receptor 4 Sales Volume Market Share by Players ()
Figure China Ephrin Type B Receptor 4 Sales Volume Market Share by Players in
Table China Ephrin Type B Receptor 4 Sales Volume (K Pcs) by Type ()
Table China Ephrin Type B Receptor 4 Sales Volume Market Share by Type ()
Figure China Ephrin Type B Receptor 4 Sales Volume Market Share by Type in
Table China Ephrin Type B Receptor 4 Sales Volume (K Pcs) by Application ()
Table China Ephrin Type B Receptor 4 Sales Volume Market Share by Application ()
Figure China Ephrin Type B Receptor 4 Sales Volume Market Share by Application in
Figure Japan Ephrin Type B Receptor 4 Sales (K Pcs) and Growth Rate ()
Figure Japan Ephrin Type B Receptor 4 Revenue (Million USD) and Growth Rate ()
Figure Japan Ephrin Type B Receptor 4 Sales Price (USD/Pcs) Trend ()
Table Japan Ephrin Type B Receptor 4 Sales Volume (K Pcs) by Players ()
Table Japan Ephrin Type B Receptor 4 Sales Volume Market Share by Players ()
Figure Japan Ephrin Type B Receptor 4 Sales Volume Market Share by Players in
Table Japan Ephrin Type B Receptor 4 Sales Volume (K Pcs) by Type ()
Table Japan Ephrin Type B Receptor 4 Sales Volume Market Share by Type ()
Figure Japan Ephrin Type B Receptor 4 Sales Volume Market Share by Type in
Table Japan Ephrin Type B Receptor 4 Sales Volume (K Pcs) by Application ()
Table Japan Ephrin Type B Receptor 4 Sales Volume Market Share by Application ()
Figure Japan Ephrin Type B Receptor 4 Sales Volume Market Share by Application in
Figure Southeast Asia Ephrin Type B Receptor 4 Sales (K Pcs) and Growth Rate ()
Figure Southeast Asia Ephrin Type B Receptor 4 Revenue (Million USD) and Growth Rate ()
Figure Southeast Asia Ephrin Type B Receptor 4 Sales Price (USD/Pcs) Trend ()
Table Southeast Asia Ephrin Type B Receptor 4 Sales Volume (K Pcs) by Players ()
Table Southeast Asia Ephrin Type B Receptor 4 Sales Volume Market Share by Players ()
Figure Southeast Asia Ephrin Type B Receptor 4 Sales Volume Market Share by Players in
Table Southeast Asia Ephrin Type B Receptor 4 Sales Volume (K Pcs) by Type ()
Table Southeast Asia Ephrin Type B Receptor 4 Sales Volume Market Share by Type ()
Figure Southeast Asia Ephrin Type B Receptor 4 Sales Volume Market Share by Type in
Table Southeast Asia Ephrin Type B Receptor 4 Sales Volume (K Pcs) by Application ()
Table Southeast Asia Ephrin Type B Receptor 4 Sales Volume Market Share by Application ()
Figure Southeast Asia Ephrin Type B Receptor 4 Sales Volume Market Share by Application in
Figure India Ephrin Type B Receptor 4 Sales (K Pcs) and Growth Rate ()
Figure India Ephrin Type B Receptor 4 Revenue (Million USD) and Growth Rate ()
Figure India Ephrin Type B Receptor 4 Sales Price (USD/Pcs) Trend ()
Table India Ephrin Type B Receptor 4 Sales Volume (K Pcs) by Players ()
Table India Ephrin Type B Receptor 4 Sales Volume Market Share by Players ()
Figure India Ephrin Type B Receptor 4 Sales Volume Market Share by Players in
Table India Ephrin Type B Receptor 4 Sales Volume (K Pcs) by Type ()
Table India Ephrin Type B Receptor 4 Sales Volume Market Share by Type ()
Figure India Ephrin Type B Receptor 4 Sales Volume Market Share by Type in
Table India Ephrin Type B Receptor 4 Sales Volume (K Pcs) by Application ()
Table India Ephrin Type B Receptor 4 Sales Volume Market Share by Application ()
Figure India Ephrin Type B Receptor 4 Sales Volume Market Share by Application in
Table Eisai Co Ltd Basic Information List
Table Eisai Co Ltd Ephrin Type B Receptor 4 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin ()
Figure Eisai Co Ltd Ephrin Type B Receptor 4 Sales Growth Rate ()
Figure Eisai Co Ltd Ephrin Type B Receptor 4 Sales Global Market Share ()
Figure Eisai Co Ltd Ephrin Type B Receptor 4 Revenue Global Market Share ()
Table Kadmon Corp LLC Basic Information List
Table Kadmon Corp LLC Ephrin Type B Receptor 4 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin ()
Figure Kadmon Corp LLC Ephrin Type B Receptor 4 Sales Growth Rate ()
Figure Kadmon Corp LLC Ephrin Type B Receptor 4 Sales Global Market Share ()
Figure Kadmon Corp LLC Ephrin Type B Receptor 4 Revenue Global Market Share ()
Table VasGene Therapeutics Inc Basic Information List
Table VasGene Therapeutics Inc Ephrin Type B Receptor 4 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin ()
Figure VasGene Therapeutics Inc Ephrin Type B Receptor 4 Sales Growth Rate ()
Figure VasGene Therapeutics Inc Ephrin Type B Receptor 4 Sales Global Market Share (
Figure VasGene Therapeutics Inc Ephrin Type B Receptor 4 Revenue Global Market Share ()
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Ephrin Type B Receptor 4
Figure Manufacturing Process Analysis of Ephrin Type B Receptor 4
Figure Ephrin Type B Receptor 4 Industrial Chain Analysis
Table Raw Materials Sources of Ephrin Type B Receptor 4 Major Players in
Table Major Buyers of Ephrin Type B Receptor 4
Table Distributors/Traders List
Figure Global Ephrin Type B Receptor 4 Sales Volume (K Pcs) and Growth Rate Forecast (2018-2025)
Figure Global Ephrin Type B Receptor 4 Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Global Ephrin Type B Receptor 4 Price (USD/Pcs) and Trend Forecast (2018-2025)
Table Global Ephrin Type B Receptor 4 Sales Volume (K Pcs) Forecast by Regions (2018-2025)
Figure Global Ephrin Type B Receptor 4 Sales Volume Market Share Forecast by Regions (2018-2025)
Figure Global Ephrin Type B Receptor 4 Sales Volume Market Share Forecast by Regions in 2025
Table Global Ephrin Type B Receptor 4 Revenue (Million USD) Forecast by Regions (2018-2025)
Figure Global Ephrin Type B Receptor 4 Revenue Market Share Forecast by Regions (2018-2025)
Figure Global Ephrin Type B Receptor 4 Revenue Market Share Forecast by Regions in 2025
Figure United States Ephrin Type B Receptor 4 Sales Volume (K Pcs) and Growth Rate Forecast (2018-2025)
Figure United States Ephrin Type B Receptor 4 Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Europe Ephrin Type B Receptor 4 Sales Volume (K Pcs) and Growth Rate Forecast (2018-2025)
Figure Europe Ephrin Type B Receptor 4 Revenue and Growth Rate Forecast (2018-2025)
Figure China Ephrin Type B Receptor 4 Sales Volume (K Pcs) and Growth Rate Forecast (2018-2025)
Figure China Ephrin Type B Receptor 4 Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Japan Ephrin Type B Receptor 4 Sales Volume (K Pcs) and Growth Rate Forecast (2018-2025)
Figure Japan Ephrin Type B Receptor 4 Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Southeast Asia Ephrin Type B Receptor 4 Sales Volume (K Pcs) and Growth Rate Forecast (2018-2025)
Figure Southeast Asia Ephrin Type B Receptor 4 Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure India Ephrin Type B Receptor 4 Sales Volume (K Pcs) and Growth Rate Forecast (2018-2025)
Figure India Ephrin Type B Receptor 4 Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Table Global Ephrin Type B Receptor 4 Sales (K Pcs) Forecast by Type (2018-2025)
Figure Global Ephrin Type B Receptor 4 Sales Volume Market Share Forecast by Type (2018-2025)
Table Global Ephrin Type B Receptor 4 Revenue (Million USD) Forecast by Type (2018-2025)
Figure Global Ephrin Type B Receptor 4 Revenue Market Share Forecast by Type (2018-2025)
Table Global Ephrin Type B Receptor 4 Price (USD/Pcs) Forecast by Type (2018-2025)
Table Global Ephrin Type B Receptor 4 Sales (K Pcs) Forecast by Application (2018-2025)
Figure Global Ephrin Type B Receptor 4 Sales Market Share Forecast by Application (2018-2025)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
Key Players
Beyond the initial clinical biotech firms, the market is increasingly influenced by large-scale pharmaceutical giants through acquisitions and licensing agreements:
-
Sanofi (Kadmon Holdings): Following the acquisition of Kadmon, Sanofi leads the development of Tesevatinib.
-
Eisai Co., Ltd.: Investigating EPHB4 inhibitors in combination with their existing oncology portfolio (Lenvatinib).
-
VasGene Therapeutics, Inc.: A pioneer in EPHB4-HSA (Human Serum Albumin) fusion proteins.
-
AstraZeneca PLC: Exploring ephrin pathways within their broader DNA Damage Response (DDR) and antibody-drug conjugate (ADC) research.
-
Bristol Myers Squibb (BMS): Researching the role of EPHB4 in immunotherapy resistance.
-
Merck & Co., Inc.: Investigating EPHB4 as a biomarker for anti-PD-1 therapy responsiveness.
-
Hengrui Medicine: Emerging Chinese leader in tyrosine kinase inhibitor (TKI) development targeting the ephrin family.
3. Comprehensive Segment Analysis
By Product/Molecule Type
-
Fusion Proteins (e.g., sEphB4-HSA): Designed to act as a "decoy" to block ephrin-B2 interaction; currently showing high efficacy in clinical trials.
-
Tyrosine Kinase Inhibitors (TKIs): Small molecules like Tesevatinib Tosylate that inhibit intracellular signaling.
-
Monoclonal Antibodies (mAbs): Targeted agents designed to trigger immune responses against EPHB4-expressing cells.
-
Antibody-Drug Conjugates (ADCs): Emerging segment using EPHB4 as a vehicle to deliver cytotoxic payloads directly to tumors.
By Application/Indication
-
Solid Tumors: The largest segment, including breast, prostate, and lung cancers.
-
Bile Duct Cancer (Cholangiocarcinoma): High unmet need area where EPHB4 targeted therapies are receiving orphan drug designations.
-
Colorectal Cancer: Focus on overcoming resistance to standard anti-VEGF therapies.
-
Head and Neck Squamous Cell Carcinoma (HNSCC): Emerging segment with promising phase II trial data.
-
Kaposi Sarcoma: Researching the role of EPHB4 in viral-induced oncogenesis.
4. Regional Analysis
-
North America: Dominates the market (approx. 42% share) due to high investment in precision medicine and a high concentration of clinical trials at institutes like MD Anderson and MSKCC.
-
Europe: Second-largest market; growth driven by the EMA’s supportive framework for orphan drugs in oncology.
-
Asia-Pacific: The fastest-growing region (CAGR of 10.2%). China and India are expanding their clinical trial infrastructure and domestic drug manufacturing capabilities.
-
LAMEA: Emerging interest in Brazil and Saudi Arabia as specialized oncology centers adopt next-gen sequencing (NGS) to identify EPHB4 targets.
